# A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery

> **NCT03921775** · PHASE3 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 330 (actual)

## Conditions studied

- Anesthesia for Elective Surgery Patients

## Interventions

- **DRUG:** Remimazolam Tosilate
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03921775
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-13
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2020-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921775, "A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03921775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*